80 related articles for article (PubMed ID: 12926126)
1. Decreased angiogenic activity in breast cancer in ever-users of oral contraceptive therapy--preliminary report.
Rydén L; Boiesen P; Jönsson PE
Anticancer Res; 2003; 23(3C):2875-8. PubMed ID: 12926126
[TBL] [Abstract][Full Text] [Related]
2. Assessment of microvessel density in core needle biopsy specimen in breast cancer.
Rydén L; Boiesen P; Jönsson PE
Anticancer Res; 2004; 24(1):371-5. PubMed ID: 15015623
[TBL] [Abstract][Full Text] [Related]
3. Microvascular density of breast cancer in bone metastasis: influence of therapy.
Lörincz T; Tóth J; Szendröi M; Tímár J
Anticancer Res; 2005; 25(4):3075-81. PubMed ID: 16080568
[TBL] [Abstract][Full Text] [Related]
4. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
5. Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer.
Fourati A; Khomsi F; El May MV; Rahal K; Gamoudi A; Boussen H; Ben Abdallah M; El May A
Tunis Med; 2007 Feb; 85(2):105-8. PubMed ID: 17665654
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of microvessel density in breast cancer of Thai women.
Kanjanapanjapol S; Wongwaisayawan S; Phuwapraisirisan S; Wilasrusmee C
J Med Assoc Thai; 2007 Feb; 90(2):282-90. PubMed ID: 17375633
[TBL] [Abstract][Full Text] [Related]
7. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
8. Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer.
Lumachi F; Ermani M; Marino F; Di Cristofaro L; Tombolan V; Brunello A; Roma A; Basso U
Anticancer Res; 2008; 28(1B):491-3. PubMed ID: 18383890
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2008; 49(2):181-8. PubMed ID: 18516324
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
[TBL] [Abstract][Full Text] [Related]
11. The influence of hormone replacement therapy on the pathology of breast cancer.
Biglia N; Sgro L; Defabiani E; De Rosa G; Ponzone R; Marenco D; Sismondi P
Eur J Surg Oncol; 2005 Jun; 31(5):467-72. PubMed ID: 15922881
[TBL] [Abstract][Full Text] [Related]
12. COX-2 expression does not correlate with microvessel density in breast cancer.
Thorat MA; Mehrotra S; Morimiya A; Badve S
Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density does not predict outcome in high grade soft tissue sarcoma.
West CC; Brown NJ; Mangham DC; Grimer RJ; Reed MW
Eur J Surg Oncol; 2005 Dec; 31(10):1198-205. PubMed ID: 15993027
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.
Vogl G; Dietze O; Hauser-Kronberger C
Histopathology; 2005 Dec; 47(6):617-24. PubMed ID: 16324200
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory.
Miller KD; Soule SE; Calley C; Emerson RE; Hutchins GD; Kopecky K; Badve S; Storniolo A; Goulet R; Sledge GW
Breast Cancer Res Treat; 2005 Jan; 89(2):187-97. PubMed ID: 15692762
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
Hansen S; Sørensen FB; Vach W; Grabau DA; Bak M; Rose C
Histopathology; 2004 May; 44(5):428-36. PubMed ID: 15139990
[TBL] [Abstract][Full Text] [Related]
18. Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: a randomized study.
Hallberg G; Persson I; Naessén T; Magnusson C
Gynecol Endocrinol; 2008 Aug; 24(8):475-80. PubMed ID: 18850387
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of angiogenesis in breast cancer.
Leek RD
Anticancer Res; 2001; 21(6B):4325-31. PubMed ID: 11908687
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and tumor grading in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2006; 47(3):251-7. PubMed ID: 17308684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
